loader
Please Wait
Applying Filters...
Close
4

Sigmak Lifesciences Sugammadex Sodium Header Sigmak Lifesciences Sugammadex Sodium Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Sugammadex, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Sugammadex

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    2D Structure
    Also known as: 343306-79-6, Bridion, Org 25969, Org-25969, Erj6x2mxv7, 343306-71-8
    Molecular Formula
    C72H104Na8O48S8
    Molecular Weight
    2178.0  g/mol
    InChI Key
    KMGKABOMYQLLDJ-VKHHSAQNSA-F
    FDA UNII
    ERJ6X2MXV7
    A gamma-cyclodextrin that functions as a reversal agent for the neuromuscular blocker ROCURONIUM BROMIDE.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    octasodium;3-[[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-10,15,20,25,30,35,40-heptakis(2-carboxylatoethylsulfanylmethyl)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methylsulfanyl]propanoate
    2.1.2 InChI
    InChI=1S/C72H112O48S8.8Na/c73-33(74)1-9-121-17-25-57-41(89)49(97)65(105-25)114-58-26(18-122-10-2-34(75)76)107-67(51(99)43(58)91)116-60-28(20-124-12-4-36(79)80)109-69(53(101)45(60)93)118-62-30(22-126-14-6-38(83)84)111-71(55(103)47(62)95)120-64-32(24-128-16-8-40(87)88)112-72(56(104)48(64)96)119-63-31(23-127-15-7-39(85)86)110-70(54(102)46(63)94)117-61-29(21-125-13-5-37(81)82)108-68(52(100)44(61)92)115-59-27(19-123-11-3-35(77)78)106-66(113-57)50(98)42(59)90;;;;;;;;/h25-32,41-72,89-104H,1-24H2,(H,73,74)(H,75,76)(H,77,78)(H,79,80)(H,81,82)(H,83,84)(H,85,86)(H,87,88);;;;;;;;/q;8*+1/p-8/t25-,26-,27-,28-,29-,30-,31-,32-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-;;;;;;;;/m1......../s1
    2.1.3 InChI Key
    KMGKABOMYQLLDJ-VKHHSAQNSA-F
    2.1.4 Canonical SMILES
    C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
    2.1.5 Isomeric SMILES
    C(CSC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])CSCCC(=O)[O-])O)O)C(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
    2.2 Other Identifiers
    2.2.1 UNII
    ERJ6X2MXV7
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 6-perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin Sodium Salt

    2. Bridion

    3. Org 25969

    4. Sugammadex

    2.3.2 Depositor-Supplied Synonyms

    1. 343306-79-6

    2. Bridion

    3. Org 25969

    4. Org-25969

    5. Erj6x2mxv7

    6. 343306-71-8

    7. Sugammadex Octasodium Salt

    8. Sugammadex (sodium)

    9. Unii-erj6x2mxv7

    10. Sugammadex Sodium [usan]

    11. Sugammadexsodium

    12. Sugammadex Sodium [usan:jan]

    13. Bridion (tn)

    14. Mk-8616

    15. Org25969

    16. Sugammadex Sodium (jan/usan)

    17. Sugammadex Sodium [jan]

    18. Chebi:90952

    19. Sugammadex Sodium [mart.]

    20. Sugammadex Sodium [who-dd]

    21. Amy12422

    22. Ex-a2600

    23. Sch-900616

    24. Sugammadex Octasodium Salt [mi]

    25. Sugammadex Sodium [orange Book]

    26. Ac-30384

    27. C13789

    28. D05940

    29. .gamma.-cyclodextrin, 6a,6b,6c,6d,6e,7f,6g,6h-octakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,7f,6g,6h-octathio-, Octasodium Salt

    30. Gamma-cyclodextrin, 6a,6b,6c,6d,6e,7f,6g,6h-octakis-s-(2-carboxyethyl)-6a,6b,6c,6d,6e,7f,6g,6h-octathio-, Octasodium Salt

    31. Octasodium 6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octakis-s-(2-carboxylatoethyl)-6,6',6'',6''',6'''',6''''',6'''''',6'''''''-octathiocyclo-alpha-(1-4)-d-octaglucopyranoside

    2.4 Create Date
    2006-07-28
    3 Chemical and Physical Properties
    Molecular Weight 2178.0 g/mol
    Molecular Formula C72H104Na8O48S8
    Hydrogen Bond Donor Count16
    Hydrogen Bond Acceptor Count56
    Rotatable Bond Count32
    Exact Mass2176.2644287 g/mol
    Monoisotopic Mass2176.2644287 g/mol
    Topological Polar Surface Area995 Ų
    Heavy Atom Count136
    Formal Charge0
    Complexity2790
    Isotope Atom Count0
    Defined Atom Stereocenter Count40
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count9
    4 Drug and Medication Information
    4.1 Drug Indication

    Reversal of neuromuscular blockade induced by rocuronium or vecuronium.

    For the peadiatric population: sugammadex is only recommended for routine reversal of rocuronium-induced blockade in children and adolescents.

    Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

    For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

    Reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

    For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    V03AB35

    V03AB35

    V03AB35

    Post Enquiry
    POST ENQUIRY